TATA Health (01255.HK) released its mid-term performance for 2025, with a net profit attributable to shareholders of HKD 20.59 million.

According to the information from the Wisdom Financial APP, TATA Health (01255.HK) released its performance for the six months ending June 30, 2025. The company's revenue was 42.118 million Hong Kong dollars, a year-on-year decrease of 41.8%; the company's attributable profit to shareholders was 20.596 million Hong Kong dollars, compared to a loss of 5.13 million Hong Kong dollars in the same period last year; the basic earnings per share was 0.08 Hong Kong dollars.